65.000 jobs to be created in 2 techno-parks

ekrem

Silver Member
Aug 9, 2005
7,954
582
93
One is for bio-medicine, one for defense-industry.
Both located in Istanbul.


Bio Istanbul

Davis Langdon picked for $2.2bn research park | Construction News | The Construction Index

The 192ha site will include the tertiary care children’s hospital, biomedical research and development facilities, and complementary commercial, retail and residential clusters. Bio Istanbul is designed to accommodate 15,000 residents and a further 35,000 working commuters. Companies will include pharmaceutical, medical technology and biomedical informatics companies.
[youtube]NFBZMlSIBOg[/youtube]




Turkey Launches Defense Techno-Park

defensenews.com

Teknopark Istanbul will operate a 700,000-square-meter space at Sabiha Gokcen Airport near here, accommodating 30,000 personnel and targeting up to $5 billion in defense and nondefense business annually, to become one of Europe's largest technology parks, said Turgut Senol, the technology center's CEO.


[youtube]Ob7d1JFgKOs[/youtube]







Bio Istanbul
bioistanbul.org - Welcome to Bio Istanbul, a medical community in the heart of Turkey.

131676295623sep11dlbcdt.jpg



Technopark Istanbul
teknoparkistanbul.com - Teknopark Istanbul

20111007presim176246380.png
 
Young Turks from abroad return come back to Motherland.

WSJ.com - Young Turks Return Home

The Brain Gain
Many well-educated Turks used to look abroad for their career opportunities. But now many think the best opportunities lie at home.

For decades, much of Turkey's top talent emigrated to Europe and the U.S., graduating from Ivy League schools and securing senior jobs in some of the world's most influential companies.

But as developed markets struggle to maintain growth, Turkey's star is rising, luring many of the country's top professionals back to the motherland.
 
Between 2012-2017 Turkey will add 364 Billion $ to its annual economic output. Accumulative.
By 2017 Israel's GDP will reach 317 Billion $.

Within 5 years, Turkey will add an Israel to Turkey's already existing GDP.

Tiny little JStone.

imf.org/external/datamapper


On Russian TV is discussed whether Turkey is becoming the Hegemon of the region, but JStone fucker runs around with his stories like "2 R&D centers in Israel, no Apple in Turkey".

[ame=http://www.youtube.com/watch?v=hpXWc_UtVoY]CrossTalk: Turkish Hegemon? - YouTube[/ame]


Tiny little you.
 
Metropolitan economic growth in the world measured by Brookings Institution:

Izmir: 4th fastest growing city in world by economic output
Ankara: 6th fastest growing city in world by economic output
Istanbul: 7th fastest growing city in world by economic output

Top performer is Shanghai.

ECONOMICS - Turkish cities hit the top 10 fastest-growing list
 
Last edited:
What "biomedicine" firms are in turkey? :badgrin:

A major US corporation purchased an Israeli "biomedicine" firm for $300 million. :clap2:
 
Would anyone in the civilized world buy anything of a biotech nature made in the shithole turkey?
 
are you like a recruiter or some shit?

I don't know if that question was directed at me...
But:

Turkey is currently the number 1 sender of students to the US in Europe and the Middle East, as well as number 10 in the world with over 12,000 students.
The Fulbright Program

Off course, we want them to return, and they actually do.
Young Turks Return Home - WSJ.com

And since crisis started, Turkish universities could also hire 1,300 academics from abroad who face budget-cuts at home:
The more than 1,300 new faces at Turkish universities – the English-literature professor from Canada, the engineering instructor from Hong Kong, the mathematician from California or the philosophy professor from Greece – have been drawn to the country by a combination of increased opportunities in Turkey, and fewer ones at home.
TURKEY - World's academic 'brain drain' becomes Turkey's 'brain rain'

Next step is directly hiring students in Middle-East, like we already do in Central-Asia. And together we'll prosper.
 
What "biomedicine" firms are in turkey? :badgrin:

A major US corporation purchased an Israeli "biomedicine" firm for $300 million. :clap2:

300 Million ?


Amgen to pay about $700 million for Turkish drug maker
Amgen to pay about $700 million for Turkish drug maker - Los Angeles Times


Now piss off, soap-boy.

The Turkish pharma company produces generic drugs, however, Israel's Teva is the largest generic pharma company IN THE WORLD.

OWNED, as usual. :badgrin: :clap2:

Amgen will pay cash to get 95.6 percent of Mustafa Nevzat, or MN Pharmaceuticals as the Istanbul-based generic-drug maker is known, the companies said in a joint statement. The transaction will boost Amgen’s presence in a region that has “large, fast-growing, priority markets,” they said.
Amgen to Acquire Mustafa Nevzat to Tap Growth in Turkey - Bloomberg

New York Times: Israeli-Based Teva Pharmaceuticals, World's Largest Generic Pharmaceutical Company
Last year, Teva's medicines filled nearly 630 million prescriptions in the United States, making it a larger domestic supplier than such pharmaceutical heavyweights as Pfizer, Novartis and Merck — combined. And as low-cost generics continue to make inroads with consumers, Teva occupies a pivotal position in a health care industry undergoing seismic changes that will give millions of more patients access to medicine.

Dozens of popular drugs are also about to lose their patent protections, opening the door to a generic boom. Already the generic industry’s leader, Teva is likely to capture even greater market share, analysts say, because it has cultivated a reputation for producing high-quality, low-cost drugs.

Like a typical generic maker, Teva doesn’t advertise or brand its no-name products. It does, however, supply medications for one out of every six prescriptions dispensed in the United States.

After at least $20 billion in acquisitions over the last decade and heady organic growth, Teva now has a market capitalization of about $53 billion

“There is a culture of excellence at Teva that frankly I don’t see a lot in pharma, period — branded companies, generics, it doesn’t matter,” says Richard B. Silver, an analyst at Barclays Capital who has been covering Teva since 1993. “They just do it better. That’s all.”
http://www.nytimes.com/2010/05/09/business/09teva.html?pagewanted=all

[ame=http://www.youtube.com/watch?v=9xEAyngb5gY&feature=related]Teva - 2011 - YouTube[/ame]
 
Last edited:

New Topics

Forum List

Back
Top